Last viewed:
SCPH
Prices are updated after-hours
SCPH
|
$4.73
3.5%
35K
|
Health Technology
(0.0% 1d)
(-6.0% 1m)
(-55.0% 1y)
(0.0% 2d)
(0.0% 3d)
(3.4% 7d)
(-31.63%
volume)
Earnings Calendar: 2024-03-21
Market Cap: $ 170,537,355
http://www.scpharmaceuticals.com
Sec
Filling
|
Patents
| 17 employees
(US) scPharmaceuticals, Inc.engages in the development of transformative pharmaceutical products for subcutaneous delivery. Its products include furosemide, used as parenteral diuretic in treating heart failure and ceftriaxone, used as parenteral antibiotic outside the hospital setting. The company was founded by Pieter Muntendam and Bertram Pitt in February 2013 and is headquartered in Burlington, MA.
heart
antibiotics
add to watch list
Paper trade
email alert is off
Press-releases
scPharmaceuticals Inc. Reports Fourth Quarter and Full-Year 2023 Financial Results and Provides Business Update
Published: 2024-03-13
(Crawled : 20:00)
- globenewswire.com
SCPH
|
$4.73
3.5%
35K
|
Health Technology
| -15.99%
| O: 3.86%
H: 2.31%
C: -6.19%
business
update
financial
results
scPharmaceuticals to Announce Fourth Quarter and Full-Year 2023 Financial Results on Wednesday, March 13, 2024
Published: 2024-03-06
(Crawled : 21:00)
- globenewswire.com
SCPH
|
$4.73
3.5%
35K
|
Health Technology
| -22.54%
| O: 0.34%
H: 4.05%
C: -4.22%
financial
results
scPharmaceuticals Announces Preliminary Unaudited Q4 and Full-Year 2023 Net FUROSCIX® Revenue
Published: 2024-01-04
(Crawled : 21:00)
- globenewswire.com
SCPH
|
$4.73
3.5%
35K
|
Health Technology
| -28.14%
| O: 3.77%
H: 0.0%
C: -3.79%
furoscix
revenue
scPharmaceuticals Inc. Reports Third Quarter 2023 Financial Results and Provides Business Update
Published: 2023-11-08
(Crawled : 21:00)
- globenewswire.com
SCPH
|
$4.73
3.5%
35K
|
Health Technology
| -11.26%
| O: -5.63%
H: 4.32%
C: -3.29%
business
update
financial
results
scPharmaceuticals to Announce Third Quarter 2023 Financial Results on Wednesday, November 8, 2023
Published: 2023-11-01
(Crawled : 20:00)
- globenewswire.com
SCPH
|
$4.73
3.5%
35K
|
Health Technology
| -12.62%
| O: 2.29%
H: 1.31%
C: -5.98%
financial
results
scPharmaceuticals to Participate in Two Upcoming Investor Conferences
Published: 2023-10-31
(Crawled : 12:00)
- globenewswire.com
SCPH
|
$4.73
3.5%
35K
|
Health Technology
| -11.09%
| O: 0.97%
H: 5.78%
C: 3.08%
scPharmaceuticals to Participate in Two Upcoming Investor Conferences - October 31, 2023
Published: 2023-10-31
(Crawled : 17:00)
- biospace.com/
SCPH
|
$4.73
3.5%
35K
|
Health Technology
| -11.09%
| O: 0.97%
H: 5.78%
C: 3.08%
scPharmaceuticals Inc. Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
Published: 2023-10-05
(Crawled : 12:00)
- globenewswire.com
SCPH
|
$4.73
3.5%
35K
|
Health Technology
| -27.8%
| O: -0.47%
H: 6.67%
C: 5.24%
nasdaq
grants
scPharmaceuticals Inc. Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) - October 5, 2023
Published: 2023-10-05
(Crawled : 14:30)
- biospace.com/
SCPH
|
$4.73
3.5%
35K
|
Health Technology
| -27.8%
| O: -0.47%
H: 6.67%
C: 5.24%
nasdaq
grants
scPharmaceuticals Announces Positive Feedback from Two FDA Meetings on Key Long-Term Growth Initiatives
Published: 2023-09-19
(Crawled : 12:00)
- globenewswire.com
SCPH
|
$4.73
3.5%
35K
|
Health Technology
| -35.63%
| O: 0.0%
H: 3.94%
C: 2.68%
fda
positive
growth
See all
Last 15 days Sec forms
File Id
Form
Published Date
Transaction Date
Direction
Code
Amount Transacted
Owned Amount